Company Filing History:
Years Active: 2002-2015
Title: Christopher Horvath: Innovator in Antibody Development
Introduction
Christopher Horvath is a notable inventor based in Taunton, MA (US), recognized for his contributions to the field of biotechnology. He holds a total of 9 patents, showcasing his innovative work in developing humanized antibodies.
Latest Patents
Among his latest patents is the invention titled "Humanized anti-CCR2 antibodies and methods of use therefor." This invention pertains to a humanized antibody or functional fragment that binds to the mammalian CC-chemokine receptor 2 (CCR2). It effectively blocks the binding of a ligand to the receptor. The invention also outlines methods for inhibiting the interaction of cells bearing mammalian CCR2 with their ligands, emphasizing its potential applications in therapeutic, prophylactic, and diagnostic methods.
Career Highlights
Christopher Horvath is currently associated with Millennium Pharmaceuticals Limited, where he continues to advance his research and development efforts. His work has significantly impacted the field of antibody therapeutics, particularly in targeting specific receptors involved in various diseases.
Collaborations
He has collaborated with notable colleagues such as Gregory J LaRosa and Walter Newman, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Christopher Horvath's work in developing humanized antibodies represents a significant advancement in biotechnology. His innovative patents and collaborations highlight his commitment to improving therapeutic methods and addressing critical health challenges.